ERMINA 3mg/20mg Film-Coated Tablet (Sold Per Piece) [PRESCRIPTION REQUIRED]

Drospirenone + Ethinylestradiol (ERMINA®) contains drospirenone 3 mg and ethinylestradiol 0.02 mg. Drospirenone and ethinylestradiol are progestogens and estrogens, fixed combinations. Drospirenone + Ethinylestradiol (ERMINA®) is available as pink, circular, biconvex film-coated tablet debossed with "159" on one side and plain on other side.

REMINDER: A doctor's prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order,(before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to OnlinePharmacy@watsons.com.ph with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription.

Origin

India

Product Usage

"Combined oral contraceptive,when taken correctly,have a failure rate of approximately 1% per year. The failure rate may increase when pills are missed or taken incorrectly. Tablets must be taken in the order directed on the package every day at about the same time with some liquid as needed. Tablet taking is continuous. One tablet is to be taken daily for 24 consecutive days followed by 4 treatment free days i.e.,day 25 through 28. Withdrawal bleeding usually starts within 3 days following the last tablet. How to start Drospirenone + Ethinylestradiol No preceding hormonal contraceptive use (in the past month): Tablet-taking has to start on day 1 of the woman's natural cycle (i.e.,the first day of her menstrual bleeding). Starting on days 2-5 is allowed,but during the first cycle a barrier method is recommended in addition for the first 7 days of tablet-taking. Changing from a combined hormonal contraceptive [combined oral contraceptive (COC)],vaginal ring,or transdermal patch: The woman should start with drospirenone + ethinylestradiol preferably on the day after the last hormone-containing tablet of her previous COC,but at the latest on the day following the usual tablet-free or hormone-free tablet interval of her previous COC. In case a vaginal ring or transdermal patch has been used,the woman should start using drospirenone + ethinylestradiol preferably on the day of removal,but at the latest when the next application would have been due. Changing from a progestogen-only-method (minipill,injection,implant) or from a progestogen-releasing intrauterine system (IUS): The woman may switch any day from the minipill (from an implant or the IUS on the day of its removal,from an injectable when the next injection would be due),but should in all of these cases be advised to additionally use a barrier method for the first 7 days of tablet-taking. Following first-trimester abortion: The woman may start immediately,when doing so,she does not need additional contraceptive measures. Following delivery or second-trimester abortion: Women should be advised to start at day 21 to 28 after delivery or second-trimester abortion. When starting later,the women should be advised to additionally use a barrier method for the first 7 days of tablet-taking. However,if intercourse has already occurred,pregnancy should be excluded before the actual start of COC use or the women has to wait for her first menstrual period. Management of missed tablets If the user is less than 24 hrs. late in taking tablet,contraceptive protection is not reduced. The woman should take the tablet as soon as she remembers and should take further tablets at the usual time. If she is more than 24 hrs. late in taking tablet,contraceptive protection may be reduced. The management of missed tablets can be guided by the following two basic rules: 1. Tablet-taking must never be discontinued for longer than 7 days (please note the recommended tablet free interval is 4 days) 2. 7 days of uninterrupted tablet-taking are required to attain adequate suppression of the hypothalamic-pituitary-ovarian-axis. Accordingly the following advice can be given in daily practice: Day 1-7: The user should take the last missed tablet as soon as she remembers,even if this means taking two tablets at the same time. She then continues to take tablets at her usual time. In addition,a barrier method such as a condom should be used for the next 7 days. If intercourse took place in the preceding 7 days,the possibility of a pregnancy should be considered. The more tablets are missed and the closer they are to the tablet free phase,the higher the risk of a pregnancy. Day 8-14: The user should take the last missed tablet as soon as she remembers,even if this means taking two tablets at the same time. She then continues to take tablets at her usual time. Provided that the woman has taken her tablets correctly in the 7 days p

Ingredients

Each of the 24 pink, circular, biconvex film-coated tablets debossed with "159" on one side and plain on the other side contains 3 mg of drospirenone and 20 mcg of ethinylestradiol

Width

6.3

Height

2.5

Depth

9